person · Reporting owner

Chutter Jessica Caroline

Disclosed activity across 2 companies

Tapewire entity: 39541
SEC CIK: 0002123815

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
PTC THERAPEUTICS, INC.PTCT · Entity 3803	Director	March 24, 2026	March 26, 2026
Tectonic Therapeutic, Inc.TECX · Entity 5328	Director	June 08, 2026	June 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PTC THERAPEUTICS, INC.

Report date March 24, 2026 · Filed March 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	7,333	Ending reported balance After 2026-03-24 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-03-24 · Grant · Acquired 4,000 · Balance 4,000 F1: Restricted stock units granted on March 24, 2026 that vest in three equal annual installments, commencing on March 24, 2027. Row 2 · 2026-03-24 · Grant · Acquired 3,333 · Balance 7,333 F2: Restricted stock units granted on March 24, 2026 that vest with respect to 1,000 shares underlying such restricted stock units on June 2, 2026, and with respect to the remaining 2,333 shares on January 2, 2027.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.54 · Expires 2036-03-23	Direct	3,475	Reported balance After 2026-03-24 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-03-24 · Grant · Acquired 3,475 · Balance 3,475 F3: This option was granted on March 24, 2026 and vests over 36 equal monthly installments, commencing on April 24, 2026.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.54 · Expires 2036-03-23	Direct	2,896	Reported balance After 2026-03-24 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-03-24 · Grant · Acquired 2,896 · Balance 2,896 F4: This option was granted on March 24, 2026 and vests over 10 equal monthly installments, commencing on April 2, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units granted on March 24, 2026 that vest in three equal annual installments, commencing on March 24, 2027.

F2: Restricted stock units granted on March 24, 2026 that vest with respect to 1,000 shares underlying such restricted stock units on June 2, 2026, and with respect to the remaining 2,333 shares on January 2, 2027.

F3: This option was granted on March 24, 2026 and vests over 36 equal monthly installments, commencing on April 24, 2026.

F4: This option was granted on March 24, 2026 and vests over 10 equal monthly installments, commencing on April 2, 2026.

Tectonic Therapeutic, Inc.

Report date June 08, 2026 · Filed June 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.10 · Expires 2036-06-07	Direct	20,400	Reported balance After 2026-06-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-06-08 · Grant · Acquired 20,400 · Balance 20,400 F1: One-third (1/3) of the shares subject to the option shall vest on June 8, 2027, and the balance shall vest in 24 equal monthly installments thereafter, subject in each case to the Reporting Person providing continuous service to the Issuer on each such date.

Filing footnotes · ownership attribution and instrument terms

F1: One-third (1/3) of the shares subject to the option shall vest on June 8, 2027, and the balance shall vest in 24 equal monthly installments thereafter, subject in each case to the Reporting Person providing continuous service to the Issuer on each such date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 08, 2026 Filed Jun 10, 2026 20:36 UTC	Tectonic Therapeutic, Inc. TECX · Entity 5328	GrantStock Option (Right to Buy) · Derivative	20,400	$0.00 Strike: $29.10	$0.00	Disclosure SEC source: 0002123815-26-000007 · form4-06102026_080616.xml · derivative · entry 1 Chutter Jessica Caroline · CIK 0002123815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,400 Underlying: Common Stock · 20,400 shares Expires 2036-06-07 F1 · derivative.exercise_date: One-third (1/3) of the shares subject to the option shall vest on June 8, 2027, and the balance shall vest in 24 equal monthly installments thereafter, subject in each case to the Reporting Person providing continuous service to the Issuer on each such date. Read SEC document
March 24, 2026 Filed Mar 26, 2026 23:41 UTC	PTC THERAPEUTICS, INC. PTCT · Entity 3803	GrantStock Option (Right to Buy) · Derivative	2,896	$0.00 Strike: $64.54	$0.00	Disclosure SEC source: 0002123815-26-000004 · form4-03262026_110330.xml · derivative · entry 4 Chutter Jessica Caroline · CIK 0002123815 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,896 Underlying: Common Stock · 2,896 shares Expires 2036-03-23 F4 · derivative.exercise_date: This option was granted on March 24, 2026 and vests over 10 equal monthly installments, commencing on April 2, 2026. Read SEC document
March 24, 2026 Filed Mar 26, 2026 23:41 UTC	PTC THERAPEUTICS, INC. PTCT · Entity 3803	GrantStock Option (Right to Buy) · Derivative	3,475	$0.00 Strike: $64.54	$0.00	Disclosure SEC source: 0002123815-26-000004 · form4-03262026_110330.xml · derivative · entry 3 Chutter Jessica Caroline · CIK 0002123815 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,475 Underlying: Common Stock · 3,475 shares Expires 2036-03-23 F3 · derivative.exercise_date: This option was granted on March 24, 2026 and vests over 36 equal monthly installments, commencing on April 24, 2026. Read SEC document
March 24, 2026 Filed Mar 26, 2026 23:41 UTC	PTC THERAPEUTICS, INC. PTCT · Entity 3803	GrantCommon Stock	3,333	$0.00	$0.00	Disclosure SEC source: 0002123815-26-000004 · form4-03262026_110330.xml · nonDerivative · entry 2 Chutter Jessica Caroline · CIK 0002123815 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,333 F2 · shares: Restricted stock units granted on March 24, 2026 that vest with respect to 1,000 shares underlying such restricted stock units on June 2, 2026, and with respect to the remaining 2,333 shares on January 2, 2027. Read SEC document
March 24, 2026 Filed Mar 26, 2026 23:41 UTC	PTC THERAPEUTICS, INC. PTCT · Entity 3803	GrantCommon Stock	4,000	$0.00	$0.00	Disclosure SEC source: 0002123815-26-000004 · form4-03262026_110330.xml · nonDerivative · entry 1 Chutter Jessica Caroline · CIK 0002123815 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Restricted stock units granted on March 24, 2026 that vest in three equal annual installments, commencing on March 24, 2027. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.